Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0770
-0.0057
(-6.89%)
At close: April 3 at 5:29:43 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
39,900
39,900
46,400
57,886
49,782
Operating Income
-39,900
-39,900
-46,400
-57,886
-49,782
Net Non Operating Interest Income Expense
400
400
700
-156
-26
Pretax Income
-39,400
-39,400
-45,800
-58,372
-49,825
Net Income Common Stockholders
-39,400
-39,400
-45,800
-58,372
-49,825
Diluted NI Available to Com Stockholders
-39,400
-39,400
-45,800
-58,372
-49,825
Basic EPS
-0.05
-0.09
-0.17
-0.11
-0.09
Diluted EPS
-0.05
-0.09
-0.17
-0.11
-0.09
Basic Average Shares
761,941.2070
420,431
271,525
517,458.7320
527,234.8940
Diluted Average Shares
761,941.2070
420,431
271,525
517,458.7320
527,234.8940
Total Operating Income as Reported
-39,800
-39,800
-46,500
-57,886
-49,782
Total Expenses
39,900
39,900
46,400
57,886
49,782
Net Income from Continuing & Discontinued Operation
-39,400
-39,400
-45,800
-58,372
-49,825
Normalized Income
-39,400
-39,400
-45,800
-58,052
-49,793
Interest Income
--
--
285
49
--
Interest Expense
--
--
238
205
26
Net Interest Income
400
400
700
-156
-26
EBIT
-39,900
-39,900
-46,400
-58,167
-49,799
EBITDA
-39,900
-39,900
-46,400
-56,672
-48,521
Reconciled Depreciation
--
--
1,675
1,495
1,278
Net Income from Continuing Operation Net Minority Interest
-39,400
-39,400
-45,800
-58,372
-49,825
Total Unusual Items Excluding Goodwill
--
--
566
-320
-32
Total Unusual Items
--
--
566
-320
-32
Normalized EBITDA
-39,900
-39,900
-46,400
-56,352
-48,489
12/31/2021 - 12/19/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APTA.ST Aptahem AB (publ)
1.4050
-8.47%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1182
+4.23%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
7.76
-3.00%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1888
-3.18%
ONCO.ST Oncopeptides AB (publ)
1.7060
+3.39%
BINV.ST BioInvent International AB (publ)
28.00
-1.58%
EGTX.ST Egetis Therapeutics AB (publ)
4.3050
+4.49%
FLUI.ST Fluicell AB (publ)
13.70
-3.39%
CAMX.ST Camurus AB (publ)
565.00
-1.40%
HNSA.ST Hansa Biopharma AB (publ)
22.64
-0.18%